Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SuperGen obtains marketing rights to Avicine

AVI BioPharma (AVII) granted SUPG exclusive U.S. sales and marketing rights to its

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE